Literature DB >> 20599940

Accelerated thymocyte maturation in IL-12Rβ2-deficient mice contributes to increased susceptibility to autoimmune inflammatory demyelination.

B Gran1, S Yu, G X Zhang, A Rostami.   

Abstract

IL-12Rβ2(-/-) mice, which are unresponsive to IL-12, develop severe experimental autoimmune encephalomyelitis (EAE). The mechanisms for enhanced autoimmunity are incompletely understood. We report that in IL-12Rβ2(-/-) mice, thymocytes undergo markedly accelerated maturation. This occurs at the transition from a double positive (DP) to a single positive (SP) phenotype, resulting in higher numbers of CD4 and CD8 SP cells, and to a lesser extent at the transition from double negative (DN) to DP cells. Accelerated maturation is observed in mice injected with anti-CD3 to mimic pre-T-cell receptor stimulation, and also in mice immunized with myelin oligodendrocyte glycoprotein (MOG) peptide to induce EAE.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599940      PMCID: PMC2939283          DOI: 10.1016/j.yexmp.2010.06.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  49 in total

1.  Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Shi-Jun Zheng; Kimberly A Maguschak; Jacques Peschon; Youhai H Chen
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

2.  Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression.

Authors:  Maria Cecilia Rodriguez-Galán; Jay H Bream; Andrew Farr; Howard A Young
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

Review 3.  Real-time measurement of signaling and motility during T cell development in the thymus.

Authors:  Nirav R Bhakta; Richard S Lewis
Journal:  Semin Immunol       Date:  2005-10-25       Impact factor: 11.130

4.  IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Ronelle A Steele; Shannon J L Gatewood; Noel R Rose
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

5.  A requirement for sustained ERK signaling during thymocyte positive selection in vivo.

Authors:  Lisa K McNeil; Timothy K Starr; Kristin A Hogquist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

6.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

7.  Role of IL-12 in intrathymic negative selection.

Authors:  B R Lúdvíksson; R O Ehrhardt; W Strober
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

8.  Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation.

Authors:  Marco L Schito; Oleg N Demidov; Shin'ichi Saito; Jonathan D Ashwell; Ettore Appella
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

9.  Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis.

Authors:  Sheela Ramanathan; Julien Gagnon; Chantal Leblanc; Robert Rottapel; Subburaj Ilangumaran
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

10.  EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes.

Authors:  Andrew Freywald; Nigel Sharfe; Charlotte D'E Miller; Cher Rashotte; Chaim M Roifman
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.